Go Pro

Corient Private Wealth LP Makes New $11.54 Million Investment in Docusign Inc. $DOCU

Docusign logo with Technology background
Image from MarketBeat Media, LLC.

Corient Private Wealth LP acquired a new position in shares of Docusign Inc. (NASDAQ:DOCU - Free Report) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 259,819 shares of the company's stock, valued at approximately $11,542,000. Corient Private Wealth LP owned about 0.14% of Docusign at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of the stock. Smartleaf Asset Management LLC raised its holdings in Docusign by 8.2% during the second quarter. Smartleaf Asset Management LLC now owns 2,169 shares of the company's stock worth $166,000 after acquiring an additional 165 shares in the last quarter. Centaurus Financial Inc. boosted its position in Docusign by 3.4% during the third quarter. Centaurus Financial Inc. now owns 5,582 shares of the company's stock valued at $402,000 after purchasing an additional 184 shares during the last quarter. Tred Avon Family Wealth LLC grew its stake in Docusign by 3.6% in the first quarter. Tred Avon Family Wealth LLC now owns 6,176 shares of the company's stock valued at $293,000 after purchasing an additional 215 shares in the last quarter. Sanctuary Advisors LLC grew its stake in Docusign by 2.4% in the fourth quarter. Sanctuary Advisors LLC now owns 9,685 shares of the company's stock valued at $662,000 after purchasing an additional 231 shares in the last quarter. Finally, First Citizens Bank & Trust Co. increased its position in shares of Docusign by 2.1% during the 1st quarter. First Citizens Bank & Trust Co. now owns 11,745 shares of the company's stock worth $557,000 after purchasing an additional 239 shares during the last quarter. Institutional investors own 77.64% of the company's stock.

Insider Activity at Docusign

In related news, insider James P. Shaughnessy sold 12,000 shares of Docusign stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $45.54, for a total transaction of $546,480.00. Following the completion of the sale, the insider directly owned 52,815 shares of the company's stock, valued at approximately $2,405,195.10. This trade represents a 18.51% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director James A. Beer sold 450 shares of Docusign stock in a transaction that occurred on Friday, August 28th. The stock was sold at an average price of $64.02, for a total value of $28,809.00. Following the sale, the director directly owned 14,586 shares of the company's stock, valued at approximately $933,795.72. The trade was a 2.99% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 91,780 shares of company stock valued at $4,386,546. Insiders own 0.59% of the company's stock.

Docusign Stock Performance

Shares of DOCU stock opened at $64.00 on Friday. The company has a market capitalization of $12.22 billion, a price-to-earnings ratio of 41.56, a PEG ratio of 1.86 and a beta of 0.87. The company has a 50-day simple moving average of $53.44 and a 200 day simple moving average of $49.15. Docusign Inc. has a 52 week low of $40.16 and a 52 week high of $86.65.

Docusign (NASDAQ:DOCU - Get Free Report) last announced its quarterly earnings results on Thursday, June 4th. The company reported $1.09 EPS for the quarter, beating analysts' consensus estimates of $0.99 by $0.10. The business had revenue of $830.24 million for the quarter, compared to analyst estimates of $824.71 million. Docusign had a net margin of 9.59% and a return on equity of 17.48%. Docusign's quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.90 EPS. Sell-side analysts forecast that Docusign Inc. will post 2.06 EPS for the current year.

Analyst Ratings Changes

A number of brokerages have recently issued reports on DOCU. Citizens Jmp reiterated a "market outperform" rating and set a $86.00 price objective on shares of Docusign in a research note on Tuesday, August 18th. Jefferies Financial Group raised their target price on shares of Docusign from $45.00 to $50.00 and gave the company a "hold" rating in a research note on Friday, June 5th. BTIG Research lowered their target price on shares of Docusign from $70.00 to $60.00 and set a "buy" rating on the stock in a report on Friday, June 5th. Citigroup reaffirmed a "market outperform" rating on shares of Docusign in a research report on Tuesday, August 18th. Finally, Weiss Ratings upgraded shares of Docusign from a "hold (c-)" rating to a "hold (c)" rating in a research note on Tuesday. Four investment analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Docusign presently has an average rating of "Hold" and an average price target of $60.27.

Read Our Latest Research Report on DOCU

Trending Headlines about Docusign

Here are the key news stories impacting Docusign this week:

  • Positive Sentiment: Analysts at Zacks said DocuSign’s upcoming earnings report could benefit from factors supporting a potential earnings beat. The articles encourage investors to monitor earnings expectations ahead of the scheduled quarterly announcement. DocuSign Earnings Expected to Grow
  • Positive Sentiment: Recent trading strength across several software stocks, including DocuSign, provided a favorable sector backdrop and helped support investor sentiment toward DOCU. Software Stocks Trade Up
  • Neutral Sentiment: DocuSign’s ARR guidance is expected to receive increased attention from Bank of America. Investors will likely scrutinize recurring-revenue growth and management’s outlook because ARR is a key indicator of future subscription performance. DocuSign ARR Guidance
  • Neutral Sentiment: Comparisons with Autodesk NASDAQ: ADSK frame DocuSign as a potential value opportunity within internet software, but the analysis does not represent a new company catalyst. DOCU Versus ADSK
  • Negative Sentiment: Director James A. Beer sold 450 shares worth approximately $28,809. The transaction reduced his holdings by 2.99%, but it was made under a pre-arranged Rule 10b5-1 trading plan and represents only a small portion of his remaining stake, limiting its significance as a bearish signal. DocuSign Director Stock Sale Filing

Docusign Profile

(Free Report)

DocuSign, Inc NASDAQ: DOCU is a leading provider of electronic signature and digital transaction management solutions. The company's flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign's Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign's platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.

Recommended Stories

Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Docusign Inc. (NASDAQ:DOCU - Free Report).

Institutional Ownership by Quarter for Docusign (NASDAQ:DOCU)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Docusign Right Now?

Before you consider Docusign, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.

While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines